Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bruzzi

Showing results (111-120 of 161) with videos related to

Pageof 17
Sort By:
Cancer Research|October 15, 1988
Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate contentF Boccardo, G Valenti, S Zanardi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancerA Ardizzoni, M Venturini, L Crinò, et al.
Cancer|November 15, 1993
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task ForceA Ardizzoni, F Salvati, R Rosso, et al.
International Journal of Immunopathology and Pharmacology|January 11, 2012
Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot studyG B Ratto, R Costa, P Maineri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2005
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomesG Cocconi, B Di Blasio, C Boni, et al.
Gastrointestinal Endoscopy|August 27, 1999
Do patients with rectosigmoid adenomas 5 mm or less in diameter need total colonoscopy?S Sciallero, L Bonelli, H Aste, et al.
British Journal of Cancer|January 1, 1995
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task ForceA Ardizzoni, G F Addamo, E Baldini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma GroupJ W Sweetenham, G Santini, W Qian, et al.
Genes, Chromosomes & Cancer|July 21, 1998
Novel germline APC variants in patients with multiple adenomasS Pedemonte, S Sciallero, V Gismondi, et al.
Tumori|December 23, 1998
Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare TumorsS Bretti, A Berruti, L Dogliotti, et al.
Pageof 17

Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Cancer Research|October 15, 1988
Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate contentF Boccardo, G Valenti, S Zanardi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancerA Ardizzoni, M Venturini, L Crinò, et al.
Cancer|November 15, 1993
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task ForceA Ardizzoni, F Salvati, R Rosso, et al.
International Journal of Immunopathology and Pharmacology|January 11, 2012
Neo-adjuvant chemo/immunotherapy in the treatment of stage III (N2) non-small cell lung cancer: a phase I/II pilot studyG B Ratto, R Costa, P Maineri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2005
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomesG Cocconi, B Di Blasio, C Boni, et al.
Gastrointestinal Endoscopy|August 27, 1999
Do patients with rectosigmoid adenomas 5 mm or less in diameter need total colonoscopy?S Sciallero, L Bonelli, H Aste, et al.
British Journal of Cancer|January 1, 1995
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task ForceA Ardizzoni, G F Addamo, E Baldini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma GroupJ W Sweetenham, G Santini, W Qian, et al.
Genes, Chromosomes & Cancer|July 21, 1998
Novel germline APC variants in patients with multiple adenomasS Pedemonte, S Sciallero, V Gismondi, et al.
Tumori|December 23, 1998
Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare TumorsS Bretti, A Berruti, L Dogliotti, et al.
Pageof 17